CORAL LABORATORIES LTD. Share Price

CORAL LABORATORIES LTD. Share Price

BSE: 524506
|
Pharmaceuticals
|
S Cap
₹ 585.00
+₹16.55 (2.91%)
1D
Last updated 14 Aug, 2026, 10:44 IST

CORAL LABORATORIES LTD. Share Price Today

As of 14 Aug 2026, CORAL LABORATORIES LTD. share price is ₹585.00. The stock opened at ₹586.00, compared to its previous close of ₹568.45. During today's trading session, CORAL LABORATORIES LTD. share price moved in the range of ₹585.00 to ₹586.00, with an average price of ₹585.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹360.00 and a high of ₹659.00.

₹585.00
2.91% up today
₹586.00
1D LOW
1D HIGH

CORAL LABORATORIES LTD. Returns Calculator

Circuit
L
H
₹540.05
₹596.85
52-week
L
H
₹360.00
₹659.00

About CORAL LABORATORIES LTD.

CORAL LABORATORIES LTD. Share Price
ISIN
INE683E01017
Sector Market Cap
₹ 202.94 Cr

Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.

CORAL LABORATORIES LTD. Financial Highlights

  • Revenue: CORAL LABORATORIES LTD. reported revenue of ₹95.80 crore in FY26 vs ₹124.12 crore in FY25. It showed a decrease of 22.82% on a yearly basis.
  • Operating Profit: CORAL LABORATORIES LTD. reported an operating profit of ₹23.11 crore in FY26 vs ₹32.47 crore in FY25. It showed a decrease of 28.83% on a year-on-year basis.
  • Net Profit: CORAL LABORATORIES LTD. reported a net profit of ₹16.38 crore in FY26 vs ₹24.16 crore in FY25. It showed a decrease of 32.20% on a yearly basis.

CORAL LABORATORIES LTD. Quarterly Result Highlights

  • CORAL LABORATORIES LTD. reported revenue of ₹29.13 crore in Mar 2026, compared with ₹24.05 crore in Dec 2025, representing an increase of 21.12% on a quarter-on-quarter (QoQ) basis.
  • CORAL LABORATORIES LTD. reported an operating profit of ₹8.29 crore in Mar 2026, compared with ₹3.70 crore in Dec 2025, representing an increase of 124.05% on a quarter-on-quarter (QoQ) basis.
  • CORAL LABORATORIES LTD. reported a profit of ₹5.22 crore in Mar 2026, compared with ₹2.78 crore in Dec 2025, reflecting an increase of 87.77% on a QoQ basis.
  • The earnings per share (EPS) of CORAL LABORATORIES LTD. stood at ₹67.61 during Mar 2026.
Know more
Promoters
71.51%
FII
0.00%
Other DII
0.00%
Retail and other
28.49%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
202.94
P/E
12.39
P/B
0.97
ROE
7.83%
D/E
0.02
ROCE
10.89%
Div. Yield
0.35%
EPS(TTM)
45.85
Turnover
0.40
EV/EBITDA
5.45
Net Margin
0.00%
Op. Margin
0.00%
ROA
6.81%
Quick Ratio
0.00
Curr. Ratio
7.70
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Coral Labs. has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Coral Labs. appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,66,155.0038.475.5813.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,25,648.0077.1513.4615.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.0322.0625.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,17,007.0025.484.3218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,18,027.0035.173.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.624.6123.76%0.0424.88%659.050.80%0.57129.18
Mankind Pharma1,00,137.0048.306.1311.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,662.0031.622.6411.07%0.1812.54%377.960.66%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,215.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

CORAL LABORATORIES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹115.01₹83.66₹78.12₹75.61
Other Income₹9.11₹6.63₹6.90₹4.81
Total Revenue₹124.11₹90.29₹85.01₹80.42
Total Expenses₹90.87₹69.40₹76.83₹69.53
Profit Before Tax₹32.47₹20.73₹8.23₹11.86
Tax₹8.31₹4.94₹1.78₹2.81
Profit After Tax₹24.16₹15.79₹6.45₹9.05
EPS - Basic₹67.61₹44.19₹18.04₹25.32
EPS - Diluted₹67.61₹44.19₹18.04₹25.32

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹33.24₹20.90₹8.19₹10.90
Income before WC changes₹30.23₹18.93₹8.57₹10.89
Change in Assets-₹17.23-₹25.02₹13.35-₹3.37
Change in Liabilities-₹6.89₹5.51-₹7.29₹2.93
Change in WC-₹24.12-₹19.51₹6.06-₹0.44
Cash flow from Operations-₹1.22-₹5.46₹12.67₹6.08
Cash flow from Investing-₹0.15₹1.40-₹2.61-₹6.05
Cash flow from Financing₹2.71₹0.01-₹6.43₹0.15
Total Cash Flow₹1.33-₹4.06₹3.62₹0.18
Cash (Start of the year)₹2.07₹6.13₹2.51₹2.32
Cash (End of the year)₹3.41₹2.07₹6.13₹2.51

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹52.92₹51.83₹50.81₹59.09
Current Assets₹176.55₹153.85₹123.54₹130.80
Total Assets₹229.46₹205.68₹174.35₹189.90
Current Liabilities₹24.96₹24.90₹11.86₹25.52
Net Current Asset₹151.59₹128.96₹111.68₹105.29
Non-Current Liabilities₹3.30₹3.28₹7.69₹8.33
Equity Capital₹201.21₹177.50₹154.80₹156.05
Total Equity & Liabilities₹229.46₹205.68₹174.35₹189.90
* All values are in INR Crore
Qty
Bid
10
568
3
565.1
50
565
1
562.4
1
562.3
Ask
Qty
585
18
585.5
24
586
104
588.5
10
590
6
Bid Total: 65
Ask Total: 162
Buy orders: 29%
Sell orders: 71%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
48.64
Neutral
ATR (14)
28.17
Neutral
STOCH(9,6)
43.87
Neutral
STOCH RSI (14)
62.97
Neutral
ADX(9)
27.39
Bearish
UO(9)
54.27
Neutral
ROC(12)
2.21
Bullish
WillR(14)
-56.13
Neutral
Period
Simple value
Exponential vaue
5D
571.14
571.51
10D
570.53
571.7
20D
575.56
574
50D
569.03
557.97
100D
499.41
525.45
Volume trend — traded volume by day
14 Aug0L
13 Aug0L
12 Aug0L
11 Aug0L
7 Aug0L
Average0L
Compare against other stocks
CORAL LABORATORIES LTD. Share Price
CORAL LABORATORIES LTD.
Pharmaceuticals
Add Stock
Add Another

CORAL LABORATORIES LTD. Share Price FAQs